参麦联合银杏达莫注射液治疗冠心病心绞痛患者临床疗效分析

An effective analysis of treating CHD and angina with Shenmai plus Yinxingdamo injection

目的:探讨参麦联合银杏达莫注射液治疗冠心病心绞痛患者临床疗效。方法:将80例患者随机分为两组,两组患者均采用常规西药治疗,治疗组加用参麦联合银杏达莫注射液静脉滴注治疗,对照组则加用丹参注射液静脉滴注治疗:两组共治疗两周后观察两组患者的心绞痛症状和心电图情况。结果:两组心绞痛疗效及心电图疗效总有效率比较,差异均有统计学意义(P<0.05)。治疗组对缓解心绞痛及心电图的改善有较好疗效,治疗组优于对照组。结论:参麦联合银杏达莫注射液治疗冠心病心绞痛有较好的治疗作用。

Objective：To investigate the clinical effects of the integrative therapy.Methods：To divide 80 patients into two groups,both took the routine therapy;the observed group took the Shenmai plus Yinxingdamo injection more;the control group took Shenmai injection more;and then angina symptoms and ECG were compared with each other.Results：The difference is significant（P0.05）.Conclusion：Shenmai plus Yinxingdamo injection is better for treatment.